Literature DB >> 25455811

Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome.

John W Warren1.   

Abstract

PURPOSE: To determine whether bladder pain syndrome/interstitial cystitis (BPS/IC) has the characteristics of a functional somatic syndrome (FSS).
MATERIALS AND METHODS: There is no accepted definition of an FSS. Consequently, this paper reviewed the literature for common FSS characteristics and for reports that BPS/IC has these characteristics.
RESULTS: Eleven articles met inclusion and exclusion criteria and yielded 18 FSS characteristics. BPS/IC patients manifest all but two: the exceptions were normal light microscopic anatomy (after hydrodistention under anesthesia, some BPS/IC bladders have Hunner's lesions and most have petechial hemorrhages) and normal laboratory tests (many BPS/IC patients have hematuria). Petechial hemorrhages and hematuria are probably related and may appear during naturally-occurring bladder distention. Without such distention, then, the 90% of BPS/IC patients without a Hunner's lesion have all the characteristics of an FSS. Comparisons in the opposite direction were consistent: several additional features of BPS/IC were found in FSSs.
CONCLUSIONS: This systematic but untested method is consistent with but does not test the hypothesis that BPS/IC in some patients might best be understood as an FSS. Like most conditions, BPS/IC is probably heterogeneous; hence only a proportion of BPS/IC cases are likely to be manifestations of an FSS. This hypothesis has several implications. Explorations of processes that connect the FSSs might contribute to understanding the pathogenesis of BPS/IC. Patients with FSSs are at risk for BPS/IC and may benefit from future preventive strategies. Therapies that are useful in FSSs also may be useful in some cases of BPS/IC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder pain syndrome; Chronic fatigue syndrome; Fibromyalgia; Functional somatic syndromes; Interstitial cystitis; Irritable bowel syndrome

Mesh:

Year:  2014        PMID: 25455811     DOI: 10.1016/j.jpsychores.2014.10.003

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  10 in total

Review 1.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

Review 2.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

Review 3.  Persistent dentoalveolar pain disorder: A putative intraoral chronic overlapping pain condition.

Authors:  Alberto Herrero Babiloni; Donald R Nixdorf; Estephan J Moana-Filho
Journal:  Oral Dis       Date:  2019-12-17       Impact factor: 3.511

4.  Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis.

Authors:  Yoshiyuki Akiyama; Jian-Rong Yao; Karl J Kreder; Michael A O'Donnell; Susan K Lutgendorf; Dan Lyu; Daichi Maeda; Haruki Kume; Yukio Homma; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-14

5.  Relationship between urodynamic patterns and lower urinary tract symptoms in Chinese women with a non-neurogenic bladder.

Authors:  Linhui Wang; Cunzhou Wang; Chuangyu Qu; Lei Yin; Danfeng Xu; Xingang Cui; Bing Liu
Journal:  Asian J Urol       Date:  2015-12-02

6.  Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model.

Authors:  Jia Li; Hui Luo; Xingyou Dong; Qian Liu; Chao Wu; Teng Zhang; Xiaoyan Hu; Yuanyuan Zhang; Bo Song; Longkun Li
Journal:  Stem Cell Res Ther       Date:  2017-05-08       Impact factor: 6.832

Review 7.  Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment.

Authors:  Yuan-Hong Jiang; Jia-Fong Jhang; Yu-Khun Lee; Hann-Chorng Kuo
Journal:  Biomedicines       Date:  2022-02-07

Review 8.  From bladder to systemic syndrome: concept and treatment evolution of interstitial cystitis.

Authors:  Sara Dinis; Joana Tavares de Oliveira; Rui Pinto; Francisco Cruz; Ca Tony Buffington; Paulo Dinis
Journal:  Int J Womens Health       Date:  2015-07-23

Review 9.  Recommendations to the primary care practitioners and the patients for managing pelvic pain, especially in painful bladder syndrome for early and better prognosis.

Authors:  Kyung Jin Chung; Adelaide Na Yeon Han; Khae Hawn Kim
Journal:  J Exerc Rehabil       Date:  2015-10-30

Review 10.  Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.

Authors:  Yoshiyuki Akiyama
Journal:  Diagnostics (Basel)       Date:  2021-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.